Neoadjuvant therapy with camrelizumab plus gemcitabine and cisplatin for patients with muscle-invasive bladder cancer: A multi-center, single-arm, phase 2 study.
Han S, Ji Z, Jiang J, Fan X, Ma Q, Hu L, Zhang W, Ping H, Wang J, Xu W, Shi B, Wang W, Wang H, Wang H, Chen S, Hu H, Guo J, Zhang S, Jiang S, Zhou Q, Xing N.
Han S, et al.
Cancer Med. 2023 Jun;12(11):12106-12117. doi: 10.1002/cam4.5900. Epub 2023 Apr 6.
Cancer Med. 2023.
PMID: 37021811
Free PMC article.
Clinical Trial.